Study of effect of individualized homoeopathic medicine on quality of life in patients on hemo-dialysis in end stage kidney disease

Evaluation of effectiveness of individualized homoeopathic medicine on quality of life in patients on hemo-dialysis in end stage kidney disease: a placebo control study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070853

Enrollment

Registered

2024-07-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Individualized Homoeopathic Medicine: One Group is given Individualized Homoeopathic Medicine after case taking. Control Intervention1: Placebo: One group is given Placebo

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of End Stage Kidney Disease on Hemodialysisfrom both the sex of all socio-economic status Patients of End Stage Kidney Disease on Hemodialysis with comorbidities of Diabetes Mellites, Hypertension, Cardiovascular Diseases. Patients of End Stage Kidney Disease on Hemodialysis for at least 3Months.

Exclusion criteria

Exclusion criteria: End Stage Kidney Disease Patients taking treatment for any other systemic disorder except morbidities leading to End Stage Kidney Disease

Design outcomes

Primary

Measure	Time frame
Outcome will be assessed in terms of: 1.Improved 2.Not ImprovedTimepoint: 1 year	—

Secondary

Measure	Time frame
IMPROVEMENT IN QUALITY OF LIFE IN PATIENT ON BASIS OF KDQOLTimepoint: 1 YEAR	—

Countries

India

Contacts

Public ContactDr Anil Vishnu Paradkar

YMT homoeopathic medical college and PG institute

ymthmc01@gmail.com9987716110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026